¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå(2025-2029³â)
Global Generic Drugs Market 2025-2029
»óǰÄÚµå : 1684947
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 221 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,617,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,787,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Á¦³×¸¯ ÀǾàǰ ½ÃÀåÀº 2024-2029³â 2,174¾ï ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 7.6% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, ½ÃÀå ȯ°æ Àü¹Ý¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ½ÃÀåÀ» ÁÖµµÇÏ´Â ¿äÀÎÀº ºê·£µå ÀǾàǰÀ» ´ëüÇÏ´Â Àú°¡ ÀǾàǰ, ½Å¾à °³¹ß ¹× ½ÃÀå °³¹ßÀÇ ¾Æ¿ô¼Ò½Ì Áõ°¡, ºê·£µå ÀǾàǰÀÇ Æ¯Çã ¸¸·á Áõ°¡ µîÀÔ´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ 2025³â
Á¾·á ¿¬µµ 2029³â
¿¹Ãø ±â°£ 2025-2029³â
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
YOY 2025 6.9%
CAGR 7.6%
Áõ°¡¾× 2,174¾ï ´Þ·¯

ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼­¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼­¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â RPAÀÇ µîÀåÀÌ ÇâÈÄ ¸î ³âµ¿¾È Á¦³×¸¯ ÀǾàǰ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ÀÌÀ¯ Áß Çϳª·Î ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, ±â¾÷ °£ ÇÕº´ ¹× ÀμöÇÕº´ Áõ°¡, º´¿ø ¼ÒÀ¯ÀÇ Á¦³×¸¯ ÀǾàǰÀÇ ÃâÇöÀº ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå Technavio ºÐ¼®

Á¦3Àå ½ÃÀå ±¸µµ

Á¦4Àå ½ÃÀå ±Ô¸ð

Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦6Àå Á¤¼º ºÐ¼®

Á¦7Àå Five Forces ºÐ¼®

Á¦8Àå ½ÃÀå ¼¼ºÐÈ­ : Åõ¿© °æ·Îº°

Á¦9Àå ½ÃÀå ¼¼ºÐÈ­ : À¯Çüº°

Á¦10Àå ½ÃÀå ¼¼ºÐÈ­ : ¿ëµµº°

Á¦11Àå °í°´ »óȲ

Á¦12Àå Áö¿ªº° »óȲ

Á¦13Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå °æÀï ºÐ¼®

Á¦16Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The generic drugs market is forecasted to grow by USD 217.4 billion during 2024-2029, accelerating at a CAGR of 7.6% during the forecast period. The report on the generic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by low-cost alternatives to branded medicines, increased outsourcing of drug discovery and development, and rising expiry of patents on branded drugs.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20256.9%
CAGR7.6%
Incremental Value$217.4 bn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's generic drugs market is segmented as below:

By Route Of Administration

By Type

By Application

By Geographical Landscape

This study identifies the advent of RPA as one of the prime reasons driving the generic drugs market growth during the next few years. Also, rising mergers and acquisitions among companies and emergence of hospital-owned generics will lead to sizable demand in the market.

The report on the generic drugs market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading generic drugs market vendors that include Amgen Inc., Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., Cadila Pharmaceuticals Ltd., Cipla Inc., DR Reddys Laboratories Ltd., Eli Lilly and Co., Fresenius SE and Co. KGaA, GlaxoSmithKline PLC, Lupin Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the generic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Route of Administration

9 Market Segmentation by Type

10 Market Segmentation by Application

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â